Child's Nervous System

, Volume 27, Issue 4, pp 671–679 | Cite as

Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas—possible role of Cannabis inhalation

  • Mansoor Foroughi
  • Glenda Hendson
  • Michael A. Sargent
  • Paul Steinbok
Case Report



Spontaneous regression of pilocytic astrocytoma after incomplete resection is well recognized, especially for cerebellar and optic pathway tumors, and tumors associated with Neurofibromatosis type-1 (NF1). The purpose of this report is to document spontaneous regression of pilocytic astrocytomas of the septum pellucidum and to discuss the possible role of cannabis in promoting regression.

Case report

We report two children with septum pellucidum/forniceal pilocytic astrocytoma (PA) tumors in the absence of NF-1, who underwent craniotomy and subtotal excision, leaving behind a small residual in each case. During Magnetic Resonance Imaging (MRI) surveillance in the first three years, one case was dormant and the other showed slight increase in size, followed by clear regression of both residual tumors over the following 3-year period. Neither patient received any conventional adjuvant treatment. The tumors regressed over the same period of time that cannabis was consumed via inhalation, raising the possibility that the cannabis played a role in the tumor regression.


We advise caution against instituting adjuvant therapy or further aggressive surgery for small residual PAs, especially in eloquent locations, even if there appears to be slight progression, since regression may occur later. Further research may be appropriate to elucidate the increasingly recognized effect of cannabis/cannabinoids on gliomas.


Pilocytic astrocytoma Septum pellucidum Fornix Tumor regression Cannabinoids Cannabis 


Financial disclosure

No financial relationships exist that are relevant to this study.

Conflict of interest statement

The authors would like to declare that no conflict of interest exists.


The University of British Columbia Institutional Review Board does not require application for formal ethics approval for case reports involving three or fewer subjects. All participating subjects provided verbal and email consent prior to participation in this study, and all research activities were performed in accordance with the ethical standards of good clinical practice as outlined in the 1964 Declaration of Helsinki.


  1. 1.
    Abdelrahim M, Newman K, Vanderlaag K, Samudio I, Safe S (2006) 3, 3′-diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5. Carcinogenesis 27(4):717–728. doi: 10.1093/carcin/bgi270 PubMedCrossRefGoogle Scholar
  2. 2.
    Abdollahzadeh M, Hoffman HJ, Blazer SI, Becker LE, Humphreys RP, Drake JM, Rutka JT (1994) Benign cerebellar astrocytoma in childhood: experience at the hospital for sick children 1980–1992. Childs Nerv Syst 10(6):380–383PubMedCrossRefGoogle Scholar
  3. 3.
    Adams IB, Martin BR (1996) Cannabis: pharmacology and toxicology in animals and humans. Addiction 91(11):1585–1614PubMedCrossRefGoogle Scholar
  4. 4.
    Ahmad A, Kong D, Sarkar SH, Wang Z, Banerjee S, Sarkar FH (2009) Inactivation of uPA and its receptor uPAR by 3, 3′-diindolylmethane (DIM) leads to the inhibition of prostate cancer cell growth and migration. J Cell Biochem 107(3):516–527. doi: 10.1002/jcb.22152 PubMedCrossRefGoogle Scholar
  5. 5.
    Ariga T, Seki T (2006) Antithrombotic and anticancer effects of garlic-derived sulfur compounds: a review. Biofactors 26(2):93–103PubMedCrossRefGoogle Scholar
  6. 6.
    Balkhoyor KB, Bernstein M (2000) Involution of diencephalic pilocytic astrocytoma after partial resection. Report of two cases in adults. J Neurosurg 93(3):484–486. doi: 10.3171/jns.2000.93.3.0484 PubMedCrossRefGoogle Scholar
  7. 7.
    Blauwblomme T, Varlet P, Goodden JR, Cuny ML, Piana H, Roujeau T, Dirocco F, Grill J, Kieffer V, Boddaert N, Sainte-Rose C, Puget S (2009) Forniceal glioma in children. Clinical article. J Neurosurg Pediatr 4(3):249–253. doi: 10.3171/2009.4.PEDS08472 PubMedCrossRefGoogle Scholar
  8. 8.
    Bodey B (2002) Spontaneous regression of neoplasms: new possibilities for immunotherapy. Expert Opin Biol Ther 2(5):459–476. doi: 10.1517/14712598.2.5.459 PubMedCrossRefGoogle Scholar
  9. 9.
    Cairncross JG, Pexman JH, Rathbone MP (1985) Post-surgical contrast enhancement mimicking residual brain tumour. Can J Neurol Sci 12(1):75PubMedGoogle Scholar
  10. 10.
    Carracedo A, Gironella M, Lorente M, Garcia S, Guzman M, Velasco G, Iovanna JL (2006) Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Res 66(13):6748–6755. doi: 10.1158/0008-5472.CAN-06-0169 PubMedCrossRefGoogle Scholar
  11. 11.
    Carracedo A, Lorente M, Egia A, Blazquez C, Garcia S, Giroux V, Malicet C, Villuendas R, Gironella M, Gonzalez-Feria L, Piris MA, Iovanna JL, Guzman M, Velasco G (2006) The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells. Cancer Cell 9(4):301–312. doi: 10.1016/j.ccr.2006.03.005 PubMedCrossRefGoogle Scholar
  12. 12.
    Chang R (2002) Bioactive polysaccharides from traditional Chinese medicine herbs as anticancer adjuvants. J Altern Complement Med 8(5):559–565. doi: 10.1089/107555302320825066 PubMedCrossRefGoogle Scholar
  13. 13.
    Chu Q, Ling MT, Feng H, Cheung HW, Tsao SW, Wang X, Wong YC (2006) A novel anticancer effect of garlic derivatives: inhibition of cancer cell invasion through restoration of E-cadherin expression. Carcinogenesis 27(11):2180–2189. doi: 10.1093/carcin/bgl054 PubMedCrossRefGoogle Scholar
  14. 14.
    Chung VQ, Tattersall M, Cheung HT (2004) Interactions of a herbal combination that inhibits growth of prostate cancer cells. Cancer Chemother Pharmacol 53(5):384–390. doi: 10.1007/s00280-003-0746-1 PubMedCrossRefGoogle Scholar
  15. 15.
    Cole WH (1981) Efforts to explain spontaneous regression of cancer. J Surg Oncol 17(3):201–209PubMedCrossRefGoogle Scholar
  16. 16.
    Dattner AM (2004) Herbal and complementary medicine in dermatology. Dermatol Clin 22(3):325–332. doi: 10.1016/j.det.2004.03.005 PubMedCrossRefGoogle Scholar
  17. 17.
    Davis CH, Joglekar VM (1981) Cerebellar astrocytomas in children and young adults. J Neurol Neurosurg Psychiatry 44(9):820–828PubMedCrossRefGoogle Scholar
  18. 18.
    Donaldson MS (2004) Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J 3:19. doi: 10.1186/1475-2891-3-19 PubMedCrossRefGoogle Scholar
  19. 19.
    Dong Y, Lisk D, Block E, Ip C (2001) Characterization of the biological activity of gamma-glutamyl-Se-methylselenocysteine: a novel, naturally occurring anticancer agent from garlic. Cancer Res 61(7):2923–2928PubMedGoogle Scholar
  20. 20.
    Due-Tonnessen BJ, Helseth E, Scheie D, Skullerud K, Aamodt G, Lundar T (2002) Long-term outcome after resection of benign cerebellar astrocytomas in children and young adults (0–19 years): report of 110 consecutive cases. Pediatr Neurosurg 37(2):71–80PubMedCrossRefGoogle Scholar
  21. 21.
    Felini MJ, Olshan AF, Schroeder JC, Carozza SE, Miike R, Rice T, Wrensch M (2009) Reproductive factors and hormone use and risk of adult gliomas. Cancer Causes Control 20(1):87–96. doi: 10.1007/s10552-008-9220-z PubMedCrossRefGoogle Scholar
  22. 22.
    Galve-Roperh I, Sanchez C, Cortes ML, Gomez del Pulgar T, Izquierdo M, Guzman M (2000) Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med 6(3):313–319. doi: 10.1038/73171 PubMedCrossRefGoogle Scholar
  23. 23.
    Gunny RS, Hayward RD, Phipps KP, Harding BN, Saunders DE (2005) Spontaneous regression of residual low-grade cerebellar pilocytic astrocytomas in children. Pediatr Radiol 35(11):1086–1091. doi: 10.1007/s00247-005-1546-z PubMedCrossRefGoogle Scholar
  24. 24.
    Gustafsson K, Christensson B, Sander B, Flygare J (2006) Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55, 212–2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma. Mol Pharmacol 70(5):1612–1620. doi: 10.1124/mol.106.025981 PubMedCrossRefGoogle Scholar
  25. 25.
    Guzman M (2003) Cannabinoids: potential anticancer agents. Nat Rev Cancer 3(10):745–755. doi: 10.1038/nrc1188 PubMedCrossRefGoogle Scholar
  26. 26.
    Guzman M, Duarte MJ, Blazquez C, Ravina J, Rosa MC, Galve-Roperh I, Sanchez C, Velasco G, Gonzalez-Feria L (2006) A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer 95(2):197–203. doi: 10.1038/sj.bjc.6603236 PubMedCrossRefGoogle Scholar
  27. 27.
    Hall W, Solowij N (1998) Adverse effects of Cannabis. Lancet 352(9140):1611–1616. doi: 10.1016/S0140-6736(98)05021-1 PubMedCrossRefGoogle Scholar
  28. 28.
    Hong C, Firestone GL, Bjeldanes LF (2002) Bcl-2 family-mediated apoptotic effects of 3, 3′-diindolylmethane (DIM) in human breast cancer cells. Biochem Pharmacol 63(6):1085–1097PubMedCrossRefGoogle Scholar
  29. 29.
    Hsu B (1980) The use of herbs as anticancer agents. Am J Chin Med 8(4):301–306PubMedCrossRefGoogle Scholar
  30. 30.
    Huang K, Whelan EA, Ruder AM, Ward EM, Deddens JA, Davis-King KE, Carreon T, Waters MA, Butler MA, Calvert GM, Schulte PA, Zivkovich Z, Heineman EF, Mandel JS, Morton RF, Reding DJ, Rosenman KD (2004) Reproductive factors and risk of glioma in women. Canc Epidemiol Biomarkers Prev 13(10):1583–1588Google Scholar
  31. 31.
    Inskip PD, Linet MS, Heineman EF (1995) Etiology of brain tumors in adults. Epidemiol Rev 17(2):382–414PubMedGoogle Scholar
  32. 32.
    Kaiser HE, Bodey B Jr, Siegel SE, Groger AM, Bodey B (2000) Spontaneous neoplastic regression: the significance of apoptosis. In Vivo 14(6):773–788PubMedGoogle Scholar
  33. 33.
    Kaschula CH, Hunter R, Parker MI (2010) Garlic-derived anticancer agents: structure and biological activity of ajoene. Biofactors 36(1):78–85. doi: 10.1002/biof.76 PubMedGoogle Scholar
  34. 34.
    Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L, Laezza C, Portella G, Bifulco M, Di Marzo V (2006) Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther 318(3):1375–1387. doi: 10.1124/jpet.106.105247 PubMedCrossRefGoogle Scholar
  35. 35.
    McKinley BP, Michalek AM, Fenstermaker RA, Plunkett RJ (2000) The impact of age and sex on the incidence of glial tumors in New York state from 1976 to 1995. J Neurosurg 93(6):932–939. doi: 10.3171/jns.2000.93.6.0932 PubMedCrossRefGoogle Scholar
  36. 36.
    Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370(9584):319–328. doi: 10.1016/S0140-6736(07)61162-3 PubMedCrossRefGoogle Scholar
  37. 37.
    Palma L, Celli P, Mariottini A (2004) Long-term follow-up of childhood cerebellar astrocytomas after incomplete resection with particular reference to arrested growth or spontaneous tumour regression. Acta Neurochir (Wien) 146(6):581–588. doi: 10.1007/s00701-004-0257-9, discussion 588CrossRefGoogle Scholar
  38. 38.
    Papac RJ (1998) Spontaneous regression of cancer: possible mechanisms. In Vivo 12(6):571–578PubMedGoogle Scholar
  39. 39.
    Rozen WM, Joseph S, Lo PA (2008) Spontaneous regression of low-grade gliomas in pediatric patients without neurofibromatosis. Pediatr Neurosurg 44(4):324–328. doi: 10.1159/000134925 PubMedCrossRefGoogle Scholar
  40. 40.
    Sanchez C, de Ceballos ML, Gomez del Pulgar T, Rueda D, Corbacho C, Velasco G, Galve-Roperh I, Huffman JW, Ramon y Cajal S, Guzman M (2001) Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer Res 61(15):5784–5789PubMedGoogle Scholar
  41. 41.
    Sanchez C, Galve-Roperh I, Canova C, Brachet P, Guzman M (1998) Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Lett 436(1):6–10PubMedCrossRefGoogle Scholar
  42. 42.
    Sarfaraz S, Adhami VM, Syed DN, Afaq F, Mukhtar H (2008) Cannabinoids for cancer treatment: progress and promise. Cancer Res 68(2):339–342. doi: 10.1158/0008-5472.CAN-07-2785 PubMedCrossRefGoogle Scholar
  43. 43.
    Sarfaraz S, Afaq F, Adhami VM, Malik A, Mukhtar H (2006) Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest. J Biol Chem 281(51):39480–39491. doi: 10.1074/jbc.M603495200 PubMedCrossRefGoogle Scholar
  44. 44.
    Saunders DE, Phipps KP, Wade AM, Hayward RD (2005) Surveillance imaging strategies following surgery and/or radiotherapy for childhood cerebellar low-grade astrocytoma. J Neurosurg 102(2 Suppl):172–178. doi: 10.3171/jns.2005.102.2.0172 PubMedGoogle Scholar
  45. 45.
    Seki T, Hosono T, Hosono-Fukao T, Inada K, Tanaka R, Ogihara J, Ariga T (2008) Anticancer effects of diallyl trisulfide derived from garlic. Asia Pac J Clin Nutr 17(Suppl 1):249–252PubMedGoogle Scholar
  46. 46.
    Smoots DW, Geyer JR, Lieberman DM, Berger MS (1998) Predicting disease progression in childhood cerebellar astrocytoma. Childs Nerv Syst 14(11):636–648PubMedCrossRefGoogle Scholar
  47. 47.
    Song K, Milner JA (2001) The influence of heating on the anticancer properties of garlic. J Nutr 131(3s):1054S–1057SPubMedGoogle Scholar
  48. 48.
    Steinbok P (1994) Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review. Neurosurgery 35(2):342–343PubMedCrossRefGoogle Scholar
  49. 49.
    Steinbok P, Poskitt K, Hendson G (2006) Spontaneous regression of cerebellar astrocytoma after subtotal resection. Childs Nerv Syst 22(6):572–576. doi: 10.1007/s00381-006-0058-y PubMedCrossRefGoogle Scholar
  50. 50.
    Suh DY, Mapstone T (2001) Pediatric supratentorial intraventricular tumors. Neurosurg Focus 10(6):E4PubMedCrossRefGoogle Scholar
  51. 51.
    Turner WM, Tsuang MT (1990) Impact of substance abuse on the course and outcome of schizophrenia. Schizophr Bull 16(1):87–95PubMedGoogle Scholar
  52. 52.
    Velasco G, Carracedo A, Blazquez C, Lorente M, Aguado T, Haro A, Sanchez C, Galve-Roperh I, Guzman M (2007) Cannabinoids and gliomas. Mol Neurobiol 36(1):60–67. doi: 10.1007/s12035-007-0002-5 PubMedCrossRefGoogle Scholar
  53. 53.
    Wigertz A, Lonn S, Hall P, Auvinen A, Christensen HC, Johansen C, Klaeboe L, Salminen T, Schoemaker MJ, Swerdlow AJ, Tynes T, Feychting M (2008) Reproductive factors and risk of meningioma and glioma. Canc Epidemiol Biomarkers Prev 17(10):2663–2670. doi: 10.1158/1055-9965.EPI-08-0406 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Mansoor Foroughi
    • 1
  • Glenda Hendson
    • 2
  • Michael A. Sargent
    • 3
  • Paul Steinbok
    • 1
  1. 1.Division of Pediatric Neurosurgery, Department of Surgery, BC Children’s HospitalVancouverCanada
  2. 2.Division of Neuropathology, Department of Pathology, BC Children’s HospitalVancouverCanada
  3. 3.Department of Radiology, BC Children’s HospitalVancouverCanada

Personalised recommendations